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Objectives: to report our initial experience with endovascular stent graft repair of a variety of thoracic aortic pathology.
Design: retrospective single center study.
Material and methods: between February 2000 and January 2002, endovascular stent graft repair was performed in 26
patients: traumatic aortic isthmus rupture (n ¼ 3), Type B dissection (n ¼ 11) and descending thoracic aortic aneurysm
(n ¼ 12). The deployed stent graft systems were AneuRx-Medtronic (n ¼ 1), Talent-Medtronic (n ¼ 13) and Excluder-
Gore (n ¼ 12).
Results: successful deployment of the stent grafts in the intended position was achieved in all patients. No hospital
mortality neither paraplegia were observed. Late, non procedure related, death occurred in four patients (15%). Access artery
complications with rupture of the iliac artery occurred in two patients and were managed by iliac-femoral bypass. The left
subclavian artery was overstented in seven patients (27%). Only the first patient received a carotido-subclavian bypass. The
mean maximal aortic diameter decreased significantly in patients treated for descending thoracic aneurysm. Only one
patient had an endoleak type II after 6 months without enlargement of the aneurysm. Complete thrombosis of the thoracic
false lumen occurred in all but one patient treated for Type B dissection 6 months postoperatively. Two patients underwent a
consecutive stent graft placement, due to a large re-entry tear distal to the first stent graft.
Conclusions: endovascular stent graft repair for Type B dissection, descending thoracic aneurysm and aortic isthmus
rupture is a promising less-invasive alternative to surgical repair. Further studies are mandatory to determine its long-term
efficacy.
Key Words: Stent graft; Endovascular; Descending thoracic aorta; Aortic dissection; Thoracic aortic aneurysm; Aortic
isthmus rupture.
Introduction
Thoracic aortic aneurysms and dissections are life-
threatening conditions and pose a significant chal-
lenge to the surgeon. The incidence of thoracic aortic
aneurysms is approximately 6 per 100 000 persons per
year.1 Surgical repair with prosthetic graft is the
traditional therapy and is associated with operative
mortalities of 5–20%.2 It is also associated with
substantial morbidity such as postoperative paraple-
gia, renal failure and need for prolonged ventilatory
support.2,3
Aortic dissections affect around 1–2 per 100 000 of
the population per year.4 Stanford Type A dissection
constitutes an emergent surgical intervention. In
contrast, medical therapy is the treatment of choice
for uncomplicated Type B dissection.5,6 Hospital
mortality rate for patients with uncomplicated Type
B dissection is equivalent whether treated medically or
surgically and varies between 9 and 20%.6 Medical
therapy, however, implicates less morbidity and less
costs. Surgical treatment is reserved for patients with
intractable pain or with complications of the dissec-
tion, such as aortic dilatation, rupture and malperfu-
sion syndrome.7
Endovascular stent graft (ESG) placement has
emerged as a less invasive alternative for repair of
the descending thoracic aorta.8 – 16 The purpose of this
study is to describe retrospectively our initial experi-
ence with ESG in the treatment of thoracic aneurysm,
Type B dissection and traumatic aortic isthmus
rupture.
Material and Methods
Between February 2000 and January 2002, 26 patients
underwent ESG repair of the descending thoracic
aorta at our institution. Three patients were treated for
a traumatic aortic isthmus rupture, 11 for a compli-
cated Type B dissection and 12 for a thoracic
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atherosclerotic aneurysm. Patient characteristics are
listed in Table 1.
Spiral computed tomographic (CT) scanning and
angiography of the aorta were performed before the
scheduled procedure in each but two patients with a
ruptured Type B dissection.
Three different commercially manufactured stent
graft systems were used. The AneuRx ESG system
(Peripheral Technologies, Santa Rosa, CA, U.S.A.) was
only used in the first patient treated. The Talent ESG
system (World Medical Corp, Sunrise, FL, U.S.A.) was
used in 13 patients and the Excluder (W.L. Gore &
Associates, Flagstaff, AZ, U.S.A.) in 12 patients. Each
endoprosthesis consists of a self-expanding nitinol
stent, covered externally by a Dacron graft or
internally by a PTFE graft (Excluder). Technical details
of the different ESG systems and their deployment
have been described previously.9,13,16 Recently, the
Excluder system was removed from the market for
thoracic use because of reported stent fractures. All
stent grafts were 10–15% oversized in diameter
compared with the diameter of the nonaffected aorta
proximal and distal to the entry tear or aneurysm inlet.
All procedures were performed in the operating
room under general anaesthesia. Vascular access
was obtained through the femoral artery after
surgical cut down. For access, the site with the
least tortuous iliac artery and the widest lumen was
chosen for ESG introduction. A 5-F measuring
pigtail catheter (Cook Australia Pty Ltd, Queens
land, Australia) was advanced into the ascending
aorta over a 0.035-inch-diameter stiff guide wire
(Terumo Corporation, Tokyo, Japan). This pigtail
catheter was used to exchange the Terumo guide
wire for a 0.035-inch-diameter Back-up Meier
(Boston Scientific Corp., Natick, MA, U.S.A.). After
intravenous administration of 5000 IU of heparin
sodium, the 20- to 24-F Talent stent graft system
itself or a 22- to 24-F Keller-Timmermans introduc-
tion kit (William Cook Europe, Bjaeverskov, DK) in
case of the Excluder system was passed over the
Back-up Meier. Angiography via contralateral per-
cutaneous femoral artery approach with the pre-
viously used measuring pigtail catheter was
performed before and after ESG deployment. Bal-
loon moulding further expanded the stent graft. In
addition to angiography, transesophageal colour
Doppler imaging was always performed. After
removal of the placement system, the arteriotomy
was closed in the usual manner.
Follow-up spiral CT was performed prior to
discharge, at 3–6 months intervals for 2 years, and
annually thereafter. Each patient underwent a follow-
up CT at least 6 months postoperatively, except the
four patients who died. The median follow-up time
was 8 months (range, 1–18 months). The procedure
was technically successful when the primary entry
tear of the aortic dissection or the inlet of the
(pseudo)aneurysm was completely excluded from
the circulation and no perigraft leakage was detected
on completion angiography or follow-up CT. In
patients with Type B dissection, we assessed the
extent of thrombosis in the thoracic and abdominal
false lumen, and measured the diameter of the true
and false lumen at the level of maximal dilatation.
Obliteration and thrombosis of the aneurysm sac or
pseudoaneurysm as well as reduction of the maximal
aortic diameter were examined in patients with
traumatic aortic rupture and atherosclerotic
aneurysm.
Statistics
Results are expressed as medians and ranges. The data
concerning aortic measurements before and after stent
graft procedure are expressed as means ^ SD and are
compared with use of the Wilcoxon matched pairs test.
p values of less than 0.05 are considered statistically
significant.
Table 1. Patient characteristics ðn5 26Þ.
Characteristic Number %
Age (yr)
Mean 64
Range 30–84
Sex
Male/Female 8/18 31/69
Comorbidity
Cigarette smoking 13 50
Arterial hypertension 18 69
Coronary artery disease 5 19
Congestive heart failure 4 15
Peripheral vascular disease 11 42
COPD 5 19
NIDDM 1 4
Hypercholesterolemia 7 27
Renal failure*
Mild 6 23
Severe, no dialysis 1 4
Severe, with dialysis 1 4
History of cerebrovascular disease 3 12
Systemic disorders† 5 19
COPD: chronic obstructive pulmonary disease; NIDDM: non insu-
line dependent diabetes mellitus.
*Mild renal failure defined as serum creatinine level 1.3–2.3 mg/dL
(115–203 mmol/L) and severe renal failure as serum creatinine level
.2.3 mg/dL (212 mmol/L).
†Systemic disorders: Marfan’s syndrome ðn ¼ 1Þ; M. Wegener ðn ¼
1Þ; amyloidosis ðn ¼ 1Þ and polymyalgia rheumatica ðn ¼ 2Þ.
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Results
Atherosclerotic aneurysm
Five of the 12 patients treated for an atherosclerotic
aneurysm were symptomatic. One of them had
paralysis of the left vocal cord, due to extrinsic
pressure of the aneurysm on the left recurrent nerve.
The other four symptomatic patients complained of
persistent interscapular pain: The localisation of the
thoracic aneurysms is listed in Table 2. The mean
aneurysmal diameter was 63 mm (range, 42–84 mm).
Only one of the 12 patients had an aneurysm,55 mm
in diameter and was treated immediately because of a
rupturing thoracic aneurysm with intramural
haematoma.
Successful exclusion of the thoracic aneurysms was
achieved in all 12 patients. The size of the stent grafts
as well as their number are listed in Table 3. For
aneurysm exclusion, several stent grafts were necess-
ary in 10 patients (83%). The mean postoperative
diameter decreased significantly ðp ¼ 0:01Þ (Table 4).
Endoleak type II was detected in three patients on
CT scan before discharge. Complete thrombosis of the
aneurysm sac with disappearance of the endoleak
occurred in two of them 6 months after ESG place-
ment. One patient still has endoleak type II without
enlargement of the aneurysm.
Intended overstenting of the left subclavian artery
occurred in three patients in order to exclude the
aneurysm completely.
Type B dissection
Eleven patients were treated for Type B dissection.
Five patients had an acute dissection (,14 days of
onset) and 6 were chronic (.14 days). Reason for
intervention as well as primary tear location are listed
in Table 5. The dissection ended at the level of the
diaphragm in two patients, extended into the abdomi-
nal aorta in five patients and distally into the iliac
arteries in four patients.
Successful covering of the primary tear occurred in
all 11 patients. Deployment of 1 ESG was sufficient in
five patients (45%) to cover the primary entry tear. In
the other six patients (55%), two ESG’s had to be
deployed. This was necessary in four patients to cover
the primary tear completely and in one patient to
cover a re-entry site just distal to the first ESG. The last
patient, who needed two ESG’s, had a very tortuous
descending aorta, which was impossible to pass with
the ESG. By deploying a first ESG at this tortuous level
and by exerting traction on both ends of a stiff guide
wire, inserted into the right brachial artery and picked
up in the groin, we could reduce the tortuosity of the
descending aorta. Only thereafter a second ESG could
be inserted to seal the primary tear.
CT images before discharge revealed complete
thrombosis of the thoracic false lumen in five patients,
partial thrombosis also in five patients and no
thrombosis in one patient. Completion aortogram in
this latter patient as well as in one patient with partial
thrombosis of the thoracic false lumen, whom maxi-
mal thoracic aortic diameter was dilated further,
depicted abundant backflow through a large re-entry
tear just distal to the first stent graft. Both patients
needed reintervention with additional ESG placement
in order to cover this large re-entry tear.
Two of the 11 patients treated for Type B dissection
died 4 months postoperatively (cfr infra). Of the
remainder nine patients, complete thrombosis of the
thoracic false lumen was evident in eight on CT-scan 6
months postoperatively. The patient, with partial
thrombosis of the thoracic false lumen, still has only
partial thrombosis at this level 18 months postopera-
tively, but without dilatation.
Although finally eight of the nine patients exhibited
complete thrombosis of the thoracic false lumen, their
abdominal false lumen remained patent without
thrombus formation. Only one patient developed
further dilatation of the abdominal false lumen with
an increase of his high abdominal aortic diameter from
40 to 46 mm 6 months after ESG placement. Because of
this dilatation and also because of atypical abdominal
complains, a classical exclusion replacement of the
thoraco-abdominal aorta was performed with left
assist device and with reimplantation of the celiac
trunk, the mesenteric superior artery and the renal
arteries.
Generally, the mean value of the maximal diameter
of the descending thoracic aorta and also the false
lumen, decreased significantly in all 11 patients treated
for Type B dissection (Table 4). One patient with a
chronic and 2 patients with an acute Type B dissection
(Fig. 1) had complete disappearance of the thoracic
false lumen after 3, 6 and 12 months respectively.
Overstenting of the left subclavian artery occurred
in four patients because of a primary tear at this level.
Table 2. Thoracic aortic aneurysm localization ðn5 12Þ.
Aorta Number
Arch þ proximal descending aorta 2
Proximal descending aorta 5
Distal descending aorta 1
Entire descending aorta 4
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Traumatic aortic isthmus rupture
Three patients were treated for a concealed isthmus
rupture and were all victim of a car accident. One
patient was referred 10 days after trauma. She was
intubated and haemodynamically stable. Multiple
other injuries were present. Two other patients were
treated with ESG because of chronic aneurysmal
dilatation of a concealed isthmus rupture 12 years
after trauma. In both patients, diagnosis of pseudoa-
neurysm was detected accidentally on chest X-rays.
One stent graft was sufficient to seal the injury site
completely in these three patients. Retraction of the
thrombus occurred in the two chronic patients, while
complete resolution of the periaortic haematoma was
seen 6 months postoperatively in the patient treated
for acute isthmus rupture. The decrease of the mean
aortic isthmus diameter after ESG placement in the
three patients was not significant ðp ¼ 0:1Þ; probably
due to the small number of patients.
Procedure time and hospital stay
The median procedure time was 82 min (range, 50–
205 mm). Sixteen patients (62%) were transferred
immediately to the ward without staying in the
intensive care unit. The median hospital stay was 6
days (range, 3–20 days).
Complications and morbidity
Three procedure related complications occurred (Table
6). Rupture of the iliac artery after withdrawal of the
device happened in 2 patients. Urgent iliac-femoral
bypass was performed in both cases. One patient
developed an ischemic right leg during the procedure.
Embolectomy with dilatation of the right femoral
artery was performed immediately after ESG deploy-
ment. Hospital mortality was 0%. None of our patients
developed paraparesis or paraplegia. Early postopera-
tive morbidity occurred in five patients (Table 6).
Four patients (15%) died late (.30 days) post-
operatively. None of them seemed to be procedure
related. Two patients with a symptomatic thoracic
aneurysm died respectively 3 and 11 months post-
operatively. Renal failure with dialysis and deterio-
ration of the general condition was the cause of death
in one patient and the second patient died because of
disseminated intravascular coagulation of unknown
reason. Two patients with an acute Type B dissection
died both 4 months postoperatively. One patient died
because of pneumonia and the second one due to
rupture of an ascending aortic aneurysm. This latter
patient was treated with ESG for a ruptured Type B
dissection and was known with an ascending aortic
dilatation of 55 mm, which was treated conservatively
because of her bad general condition.
Table 3. Size and number of stent grafts for ESG treatment.
Variable Traumatic isthmus injury ðn ¼ 3Þ Thoracic aneurysm ðn ¼ 12Þ Type B dissection ðn ¼ 11Þ
Length of ESG (mm)
Median 100 100 100
Range 100 90–200 60–200
Diameter of ESG (mm)
Median 28 42 36
Range 26–31 34–46 32–42
Number of ESG
Median 1 2 2
Range 1 1–5 1–2
Table 4. Comparison of the diameter of the aorta, true and false lumen on CT-scan pre-and postoperatively ðn5 26Þ.
Type of lesion Preoperative diameter* (mm ^ SD) Latest follow-up diameter (mm ^ SD) p value
Thoracic aneurysm ðn ¼ 12Þ
Aorta 63 ^ 11 57 ^ 12 0.01
Traumatic isthmus rupture ðn ¼ 3Þ
Aorta 45 ^ 9 38 ^ 11 0.1
Type B dissection ðn ¼ 11Þ
Aorta 51 ^ 14 46 ^ 13 0.01
True lumen 23 ^ 3 31 ^ 3 0.003
False lumen 28 ^ 13 15 ^ 14 0.003
*The diameters of the aorta, true and false lumen were expressed as mean values of the maximal diameter and were measured at the same
levels before and after ESG placement.
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Discussion
Thoracic aortic dissections and aneurysms, together
with traumatic injuries remain a fascinating problem
for the surgeon. Early surgical mortality rate still
ranges from 5 to 20%3 and exceeds 50% in high-risk
patients with end-organ ischemia.17 Recently, many
groups introduced endoluminal aortic reconstruction
with stent graft deployment and they reported
reduced morbidity and mortality, ranging from 0 to
16%.8 – 15
Safe ESG placement requires distal arterial access of
sufficient size with limited tortuosity and sufficient
proximal and distal neck. In our experience, rupture of
the iliac artery occurred in two patients (8%), once
with the Talent and once with the Excluder device. The
first sign of iliac rupture after withdrawal of the device
was bradycardia, due to peritoneal reaction with vagal
reflex. Urgent iliac-femoral bypass was performed in
both cases. Smaller devices may prevent this compli-
cation in the future.9 Furthermore, we agree with
Cambria and colleagues that the potential for such
complications constitutes a compelling argument for
continued use of general anaesthesia in a fully
equipped operating room.12 For adequate fixation
and safe ESG deployment, a normal aorta of at least
1 cm in length is necessary
In addition to intraprocedural contrast angiogra-
phy, we want to highlight the importancy of colour
Doppler transesophageal echocardiography. TEE is
very useful for exact visualization of the origin of the
Table 5. Treatment indication for Type B dissection.
Type B dissection ðn ¼ 11Þ Acute ðn ¼ 5Þ Chronic ðn ¼ 6Þ
Indication
Persistent pain 5 1
Diameter (.55 mm) 1 5
Rupture 2 –
Primary tear localization
Left subclavian artery 2 2
Isthmus 1 -
Lower descending aorta 2 4
Table 6. Per- and postoperative morbidity ðn5 26Þ.
Type of complication n (%)
Procedure related complications 3 (11%)
Iliac artery rupture 2
Peripheral emboli 1
Early postoperative morbidity 5 (19%)
Acute cholecystitis 1
Pneumonia 1
Groin pseudoaneurysm 1
Transient renal failure 1
Transient aphasia 1
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dissection and aneurysm, which can be difficult with
angiography alone. Furthermore TEE provides useful
information for exact positioning of the ESG and
detects accurately perigraft leakage as well as the
patency of the false lumen in case of Type B
dissection.18 – 20
Intended overstenting of the left subclavian artery
with ESG placement just distal to the left common
carotid artery occurred in seven patients (27%). Only
the first patient received a carotido-subclavian shunt
prior to ESG deployment. In the following six patients,
we did not perform a carotido-subclavian shunt and
none of them developed vertebrobasilar or left arm
ischemia. Coverage of the left subclavian artery has
been reported to be apparently safe21 and our own
experience with seven cases supports this view. We
also agree with the statement by Dake22 that a
prophylactic transposition of the subclavian artery
must not be forced. If vertebrobasilar or arm ischemia
occurs, secondary revascularization with carotido-
subclavian shunt or transposition can be performed.
Endovascularly excluded thoracic aortic aneurysms
decrease in size similar to that found in abdominal
aneurysms. Sac shrinkage of about 10% yearly was
detected by Greenberg et al.23 Resch et al.24 documen-
ted mean aneurysm shrinkage of about 4 mm at 12
months follow-up. We noted a mean aneurysmal sac
shrinkage of 6 mm in the 12 patients treated for
atherosclerotic aneurysms.
Our treatment strategy for complicated Type B
dissection is exclusion of the primary entry tear in
order to induce thrombosis and retraction of the
thoracic false lumen. Stent graft placement creates a
remodelling of the aorta by expansion of the true
lumen and thrombosis and retraction of the false
lumen, which mimics the natural healing process of
the aorta.11 In our group, complete thrombosis of the
thoracic false lumen occurred in eight of nine patients
6 months postoperatively. The patient with partial
thrombosis of the thoracic false lumen still has only
partial thrombosis without dilatation 18 months post-
operatively. Indeed, even if only partial false lumen
thrombosis is achieved, it still can be advantageous by
protecting the false lumen from enlarging over time
since systemic blood pressure is no longer directly
transmitted from the aorta through a large primary
tear.25 In view of these results we believe that, also for
chronic Type B dissection, covering of the primary tear
alone without covering of the entire dilated thoracic
aorta, is sufficient to induce thrombosis of the thoracic
false lumen.
Furthermore, one may question whether this
therapy should be offered in all patients with an
acute Type B dissection, even when uncomplicated.
Approximately 20% of patients, treated medically for a
Type B dissection, indeed, develop aneurysmal dilata-
tion of the thoracic false lumen during the first 5 years
after diagnosis. Although we cannot draw any con-
crete conclusions from the short-term follow-up of this
small number of patients, it may be reasonable to
speculate that ESG treatment in all patients with an
acute type B dissection may limit this complication.10,
26,27
While complete thrombosis of the thoracic false
lumen occurred in eight of nine patients treated for
Type B dissection, the abdominal false lumen
remained patent in all patients with infrarenal exten-
sion of the false lumen. Re-entry sites, usually near the
exit site of major splanchnic branch vessels, are
responsible for these natural fenestrations (Fig. 2).10,
28 Natural fenestrations are holes in the septum of the
dissection when it has been ripped off the branch
vessels and they account for the continued perfusion
of the false lumen when the primary entry tear has
been sealed with a stent graft. Only one of these
patients developed further dilatation of the abdominal
false lumen. Six months after ESG placement, this
patient underwent a classical exclusion replacement of
his high abdominal aorta.
We did not encounter spinal cord ischemia,
although the distal thoracic aorta was stented in five
patients. In addition, two patients underwent previous
open AAA repair, a circumstance that increases the
risk of paraplegia in the Stanford experience.29 Green-
berg et al., on the other hand, correlated more
extensive lengths of ESG as increasing spinal cord
ischemia complications, which they observed in 12%
of their patients.23 This latter figure must be con-
sidered a maximum for spinal cord complications,
because most reports are in the 0 to 3% range.
Monitoring evoked spinal cord potentials during
temporary interruption of the intercostal arteries by
test deployment of a collapsable stent graft,30 may aid
in identifying patients at risk for spinal cord ischemia,
in whom conversion to open repair31 or prophylactic
cerebrospinal fluids drainage may be performed.32
Multiple circumstances are in favour for the ESG
technique compared with classical thoracic aorta
surgery in preventing spinal cord ischemia. The total
procedure time is much shorter with only a small
amount of blood loss. There is no need for circulatory
Fig. 1. Acute Type B dissection before and after stent graft
repair. Preoperative thoracic aortogram (a) and contrast-
enhanced CT (b) with visualization of the primary entry tear
(arrow), true (T) and false (F) lumen. Postoperative CT (c)
after 6 months shows the true lumen with complete
obliteration of the false lumen.
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arrest and cross clamping of the aorta, with associated
ischemia and potential reperfusion injury.11 The
sudden deployment of the stent graft probably does
not produce a steal phenomenon in the perfusion of
the spinal cord.9 Furthermore, ESG procedure is
associated with less postoperative respiratory failure
and less prolonged hypotension, which reduces the
risk of delayed paraplegia.11
Finally, we can remark that stent graft procedures
are substantially cost saving, as compared with
classical thoracic surgery, because of reduced need
for intensive care and shorter hospital stay.11 More-
over, patients recover much faster.
In conclusion, our results demonstrate that endo-
vascular stent graft placement for Type B dissection,
thoracic aortic aneurysm and trauma is a save
alternative to surgical repair. Further studies are
mandatory to determine the long-term efficacy and
durability of this innovative technique.
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